UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia

Journal of clinical oncology, 2014-02, Vol.32 (4), p.306-311

2014

Volltextzugriff (PDF)

Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity

Leukemia, 2018-02, Vol.32 (2), p.520-531

2018

Volltextzugriff (PDF)

Tumor Boards and the Quality of Cancer Care

JNCI : Journal of the National Cancer Institute, 2013-01, Vol.105 (2), p.113-121

2013

Volltextzugriff (PDF)

Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia

Journal of clinical oncology, 2016-12, Vol.34 (36), p.4323-4328

2016

Volltextzugriff (PDF)

Utilization Management Trends in Medicare Part D Oncology Drugs, 2010-2020

JAMA : the journal of the American Medical Association, 2023-07, Vol.330 (3), p.278

2023

Volltextzugriff (PDF)

Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study

BMJ (Online), 2014-03, Vol.348 (mar04 4), p.g1219-g1219

2014

Volltextzugriff (PDF)

Mind the Gap: Why Closing the Doughnut Hole Is Insufficient for Increasing Medicare Beneficiary Access to Oral Chemotherapy

Journal of clinical oncology, 2016-02, Vol.34 (4), p.375-380

2016

Volltextzugriff (PDF)

Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology

Oncogene, 2012-09, Vol.31 (38), p.4171-4181

2012

Volltextzugriff (PDF)

A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy

Oncotarget, 2017-10, Vol.8 (51), p.89256-89268

2017

Volltextzugriff (PDF)

Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia

Oncogene, 2013-11, Vol.32 (46), p.5359-5368

2013

Volltextzugriff (PDF)

Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies

Journal of clinical oncology, 2005-05, Vol.23 (15), p.3396-3403

2005

Volltextzugriff (PDF)

Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD

Leukemia, 2023-07, Vol.37 (7), p.1444-1453

2023

Volltextzugriff (PDF)

Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells

Stem cells (Dayton, Ohio), 2010-08, Vol.28 (8), p.1446-1455

2010

Volltextzugriff (PDF)

Oncologists’ perspectives on post‐cancer treatment communication and care coordination with primary care physicians

European journal of cancer care, 2017-07, Vol.26 (4), p.e12628-n/a

2017

Volltextzugriff (PDF)

Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation

Oncogene, 2013-08, Vol.32 (31), p.3616-3626

2013

Volltextzugriff (PDF)

Implications of false‐positive results for future cancer screenings

Cancer, 2018-06, Vol.124 (11), p.2390-2398

2018

Volltextzugriff (PDF)

Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism

Leukemia, 2008-06, Vol.22 (6), p.1191-1199

2008

Volltextzugriff (PDF)

Explaining racial differences in prostate cancer mortality

Cancer, 2012-09, Vol.118 (17), p.4280-4289

2012

Volltextzugriff (PDF)

For uninsured cancer patients, outpatient charges can be costly, putting treatments out of reach

Health Affairs, 2015-04, Vol.34 (4), p.584-591

2015

Volltextzugriff (PDF)

Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies

Leukemia, 2018-11, Vol.32 (11), p.2388-2398

2018

Volltextzugriff (PDF)

A snapshot of smokers after lung and colorectal cancer diagnosis

Cancer, 2012-06, Vol.118 (12), p.3153-3164

2012

Volltextzugriff (PDF)

An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring

Leukemia, 2020-05, Vol.34 (5), p.1394-1406

2020

Volltextzugriff (PDF)

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

Cancer, 2006-04, Vol.106 (7), p.1569-1580

2006

Volltextzugriff (PDF)

DNA Repair Initiated in Chronic Lymphocytic Leukemia Lymphocytes by 4-Hydroperoxycyclophosphamide Is Inhibited by Fludarabine and Clofarabine

Clinical cancer research, 2001-11, Vol.7 (11), p.3580-3589

2001

Volltextzugriff (PDF)

Comparing hospital and telephone follow‐up for patients treated for stage–I endometrial cancer (ENDCAT trial): a randomised, multicentre, non‐inferiority trial

BJOG : an international journal of obstetrics and gynaecology, 2017-01, Vol.124 (1), p.150-160

2017

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(221)
Mit Volltextzugriff
(196)

Publikationsform

Artikel
(239)

Sprache

Englisch
(239)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(238)
Science & Technology
(238)
Humans
(206)
Biological And Medical Sciences
(132)
Medical Sciences
(130)
Middle Aged
(125)
Female
(120)
Male
(120)
Adult
(113)
Aged
(91)
Pharmacology. Drug Treatments
(68)
Antineoplastic Agents
(61)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(57)
Prognosis
(54)
Adolescent
(53)
Hematology
(53)
Chemotherapy
(50)
Hematologic And Hematopoietic Diseases
(37)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(37)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer
(49)
Journal Of Clinical Oncology
(43)
Leukemia
(24)
Bone Marrow Transplantation
(12)
Clinical Cancer Research
(12)
Cancer Treatment Reports
(11)
Cancer Research
(10)
Leukemia & Lymphoma
(10)
Jnci : Journal Of The National Cancer Institute
(6)
Oncogene
(6)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia

Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity

Tumor Boards and the Quality of Cancer Care

Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia

Utilization Management Trends in Medicare Part D Oncology Drugs, 2010-2020

Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study

Mind the Gap: Why Closing the Doughnut Hole Is Insufficient for Increasing Medicare Beneficiary Access to Oral Chemotherapy

Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology

A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy

Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia

Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies

Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD

Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells

Oncologists’ perspectives on post‐cancer treatment communication and care coordination with primary care physicians

Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation

Implications of false‐positive results for future cancer screenings

Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism

Explaining racial differences in prostate cancer mortality

For uninsured cancer patients, outpatient charges can be costly, putting treatments out of reach

Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies

A snapshot of smokers after lung and colorectal cancer diagnosis

An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

DNA Repair Initiated in Chronic Lymphocytic Leukemia Lymphocytes by 4-Hydroperoxycyclophosphamide Is Inhibited by Fludarabine and Clofarabine

Comparing hospital and telephone follow‐up for patients treated for stage–I endometrial cancer (ENDCAT trial): a randomised, multicentre, non‐inferiority trial

Aktive Filter

Suchergebnisse filtern